Sarepta Therapeutics (SRPT) Stock Is About To Soar

0

Sarepta Therapeutics Inc (NASDAQ: SRPT)

Sarepta Therapeutics is an incredibly strong stock in the biotechnology space. However, it seems as though the stock is going to get stronger, and it’s going to happen soon. I’m not quite sure what’s up their sleeve, but insider trading shows that something big is likely to happen as SRPT. Today, we’ll talk about why it’s important to watch insider trading, what we’re seeing from SRPT, and what we can expect to see moving forward. So, let’s get right to it!

Trade smarter and make more money with Tradespoon!

Why It’s Important To Watch Insider Trading

As investors, we really don’t have very much information available to us. Sure, we can watch technical data and focus on the fundamental data we know, but the truth is, most fundamentals are outdated by the time we have access to them. Nonetheless, there is one clue that often leads to big gains (or big declines); that clue is insider trading. The bottom line is that no one knows more about a publicly-traded company than those on the inside. When they start to sell shares in the company for which they are insiders, we can expect to see declines. However, when they start to buy shares, we can expect that something big is just around the corner, and SRPT insiders are buying shares!

We’re Seeing Quite A Bit Of Insider Activity In Sarepta Therapeutics

Over the past week or so, we’ve seen quite a bit of positive insider activity at SRPT. In fact, over this short period of time, three directors at the company have made the decision to purchase shares. Between the three insiders, a total of 154,500 shares were purchased. The prices on these shares ranged from $14.54 per share to $16.54 per share, placing the total cost to the insiders at approximately $2.5 million. When one insider purchases shares, we expect to see something good happen. However, in the case of SRPT, three insiders started loading up on shares at the same time. While I’m not sure what they see coming around the corner, there’s got to be a reason these three insiders jumped in on $2.5 million in shares of the company.

What We Can Expect To See Moving Forward

As mentioned above, I’m in the dark just like you when it comes to what’s coming. The truth is that I have no crystal ball, nor do I have any other way to look into the future. However, I do know that when we start to see big insider buys, those insiders are buying for a reason. In the case of SRPT, I don’t see this any different. The insiders made educated decisions to purchase shares. Why? I have no idea, but they did!

With that said, I’m expecting to see something big from the company relatively soon. Maybe they’ve reached a big time medical breakthrough, maybe they are expecting to move forward with a new clinical study, maybe they just have great financial data to report. Nonteheless, something is coming so we need to be watching closely. This could open the door to incredible trading opportunities.

Don’t waste your time! Click here to find winning trades in minutes!

What Do You Think?

Where do you think SRPT is headed and why? Let us know your opinion in the comments below!

[Image Courtesy of Wikipedia]

Previous articleHorizon Pharma (HZNP) Stock: Get Ready For More Gains
Next articleBiotech Stock News (GWPH)(CPXX)(VTAE)
Hey, Im Joshua, the founder of CNA Finance. I enjoy following the trends in the market and finding the catalysts that are making the moves. If you want to get in contact with me, leave a comment below or email me at CNAFinanceHelp@gmail.com Please keep in mind that I am not an investment advisor and nor is CNA Finance. This is a news and information gathering outlet. We may work directly with some of the companies that we write about. If we have a business relationship with an issuer, we will mention that in the articles. We also have various affiliate relationships with advertisers and may be paid if you sign up for a service that you were referred to through our website.

LEAVE A REPLY

Please enter your comment!
Please enter your name here